Cargando…
A Synergistic Combination of Niclosamide and Doxorubicin as an Efficacious Therapy for All Clinical Subtypes of Breast Cancer
SIMPLE SUMMARY: Chemotherapy is the gold standard treatment option for metastatic cancers. However, the efficacy of chemotherapy is limited due to the development of resistance. The aberrantly expressed Wnt/β-catenin signaling pathway acts as one of the major cancer drivers that also causes the deve...
Autores principales: | Lohiya, Garima, Katti, Dhirendra S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268129/ https://www.ncbi.nlm.nih.gov/pubmed/34209317 http://dx.doi.org/10.3390/cancers13133299 |
Ejemplares similares
-
Study on the Synergistic Molluscicidal Effect of Pedunsaponin A and Niclosamide
por: Yang, Chunping, et al.
Publicado: (2022) -
Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
por: Kang, Hee Eun, et al.
Publicado: (2021) -
Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Ayerbe-Algaba, Rafael, et al.
Publicado: (2018) -
Combinational Treatment of Doxorubicin With Neoadjuvant Docetaxel for
Different Subtypes of Patients With Breast Cancer
por: Wang, Ling-Cheng, et al.
Publicado: (2020) -
Niclosamide encapsulated polymeric nanocarriers for targeted cancer therapy
por: Jain, Nishant Kumar, et al.
Publicado: (2019)